Wawersik S, Purcell P, Rauchman M, Dudley A T, Robertson E J, Maas R
Division of Genetics, Brigham & Women's Hospital, Harvard Medical School, Boston, Massachusetts, 02115, USA.
Dev Biol. 1999 Mar 1;207(1):176-88. doi: 10.1006/dbio.1998.9153.
Targeted inactivation of the Bmp7 gene in mouse leads to eye defects with late onset and variable penetrance (A. T. Dudley et al., 1995, Genes Dev. 9, 2795-2807; G. Luo et al., 1995, Genes Dev. 9, 2808-2820). Here we report that the expressivity of the Bmp7 mutant phenotype markedly increases in a C3H/He genetic background and that the phenotype implicates Bmp7 in the early stages of lens development. Immunolocalization experiments show that BMP7 protein is present in the head ectoderm at the time of lens placode induction. Using an in vitro culture system, we demonstrate that addition of BMP7 antagonists during the period of lens placode induction inhibits lens formation, indicating a role for BMP7 in lens placode development. Next, to integrate Bmp7 into a developmental pathway controlling formation of the lens placode, we examined the expression of several early lens placode-specific markers in Bmp7 mutant embryos. In these embryos, Pax6 head ectoderm expression is lost just prior to the time when the lens placode should appear, while in Pax6-deficient (Sey/Sey) embryos, Bmp7 expression is maintained. These results could suggest a simple linear pathway in placode induction in which Bmp7 functions upstream of Pax6 and regulates lens placode induction. At odds with this interpretation, however, is the finding that expression of secreted Frizzled Related Protein-2 (sFRP-2), a component of the Wnt signaling pathway which is expressed in prospective lens placode, is absent in Sey/Sey embryos but initially present in Bmp7 mutants. This suggests a different model in which Bmp7 function is required to maintain Pax6 expression after induction, during a preplacodal stage of lens development. We conclude that Bmp7 is a critical component of the genetic mechanism(s) controlling lens placode formation.
在小鼠中对Bmp7基因进行靶向失活会导致迟发性且具有可变外显率的眼部缺陷(A.T. 达德利等人,1995年,《基因与发育》9卷, 2795 - 2807页;G. 罗等人,1995年,《基因与发育》9卷, 2808 - 2820页)。在此我们报告,在C3H/He遗传背景下,Bmp7突变体表型的表现度显著增加,并且该表型表明Bmp7在晶状体发育的早期阶段发挥作用。免疫定位实验表明,在晶状体板诱导时,BMP7蛋白存在于头部外胚层中。利用体外培养系统,我们证明在晶状体板诱导期间添加BMP7拮抗剂会抑制晶状体形成,这表明BMP7在晶状体板发育中发挥作用。接下来,为了将Bmp7整合到控制晶状体板形成的发育途径中,我们检测了Bmp7突变体胚胎中几种早期晶状体板特异性标志物的表达。在这些胚胎中,就在晶状体板应该出现之前,Pax6在头部外胚层的表达消失,而在Pax6缺陷(Sey/Sey)胚胎中,Bmp7的表达得以维持。这些结果可能暗示了一种在板诱导中的简单线性途径,其中Bmp7在Pax6的上游发挥作用并调节晶状体板诱导。然而,与这种解释相悖的是,在Sey/Sey胚胎中不存在分泌型卷曲相关蛋白 - 2(sFRP - 2)的表达,sFRP - 2是Wnt信号通路的一个组成部分,在前体晶状体板中表达,但在Bmp7突变体中最初存在。这表明了一种不同的模型,其中在晶状体发育的前板阶段诱导后,需要Bmp7的功能来维持Pax6的表达。我们得出结论,Bmp7是控制晶状体板形成的遗传机制的关键组成部分。